title: Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin.
abstract: Protein entrapment and high-performance affinity chromatography were used with zonal elution to examine the changes in binding that occurred for site-specific probes and various sulfonylurea drugs with normal and glycated forms of human serum albumin (HSA). Samples of this protein in a soluble form were physically entrapped within porous silica particles by using glycogen-capped hydrazide-activated silica; these supports were then placed into 1.0 cm × 2.1 mm inner diameter columns. Initial zonal elution studies were performed using (R)-warfarin and L-tryptophan as probes for Sudlow sites I and II (i.e., the major drug binding sites of HSA), giving quantitative measures of binding affinities in good agreement with literature values. It was also found for solutes with multisite binding to the same proteins, such as many sulfonylurea drugs, that this method could be used to estimate the global affinity of the solute for the entrapped protein. This entrapment and zonal approach provided retention information with precisions of ±0.1-3.3% (± one standard deviation) and elution within 0.50-3.00 min for solutes with binding affinities of 1 × 10(4)-3 × 10(5) M(-1). Each entrapped-protein column was used for many binding studies, which decreased the cost and amount of protein needed per injection (e.g., the equivalent of only 125-145 pmol of immobilized HSA or glycated HSA per injection over 60 sample application cycles). This method can be adapted for use with other proteins and solutes and should be valuable in high-throughput screening or quantitative studies of drug-protein binding or related biointeractions.
authors: Department of Chemistry, University of Nebraska-Lincoln, Lincoln, NE 68588-0304, USA.
authors: Abby J
authors: AJ
authors: Jackson
authors: Jeanethe
authors: J
authors: Anguizola
authors: Erika L
authors: EL
authors: Pfaunmiller
authors: David S
authors: DS
authors: Hage
mesh_terms: D000925:Anticoagulants / Q000737:chemistry*; D001665:Binding Sites; D002846:Chromatography, Affinity / Q000379:methods*; D017127:Glycation End Products, Advanced; D006801:Humans; D007700:Kinetics; D012709:Serum Albumin / Q000737:chemistry*; D014364:Tryptophan / Q000737:chemistry; D014859:Warfarin / Q000737:chemistry*; D000093423:Glycated Serum Albumin
chemical_list: D000925:Anticoagulants; D017127:Glycation End Products, Advanced; D012709:Serum Albumin; D014859:Warfarin; D014364:Tryptophan; D000093423:Glycated Serum Albumin
references: J Chromatogr A. 2012 Dec 21;1269:198-207
references: 23010249
references: Chirality. 2006 Sep;18(9):667-79
references: 16823814
references: J Biol Chem. 1983 May 25;258(10):6142-6
references: 6853480
references: J Sep Sci. 2009 Mar;32(5-6):835-53
references: 19278006
references: J Pharm Biomed Anal. 2010 Nov 2;53(3):811-8
references: 20537832
references: Anal Chem. 2004 Dec 1;76(23):7013-22
references: 15571354
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2775-81
references: 20829128
references: J Biol Chem. 1963 Oct;238:3241-8
references: 14085368
references: Mol Pharmacol. 1976 Nov;12(6):1052-61
references: 1004490
references: Mol Pharmacol. 1975 Nov;11(6):824-32
references: 1207674
references: Anal Chem. 1985 Sep;57(11):1099A-1101A, 1102A-1106A passim
references: 4051185
references: Anal Biochem. 2010 Sep 1;404(1):106-8
references: 20470745
references: J Chromatogr A. 1996 Feb 23;725(2):273-85
references: 8900576
references: J Pharm Pharmacol. 1977 Dec;29 Suppl:33P
references: 22663
references: Clin Chim Acta. 2011 Aug 17;412(17-18):1606-15
references: 21601565
references: Biochim Biophys Acta. 2007 Jun;1770(6):933-42
references: 17368729
references: J Chromatogr A. 1994 May 27;669(1-2):9-19
references: 8055106
references: Mol Pharmacol. 1971 Mar;7(2):209-18
references: 5125855
references: Anal Bioanal Chem. 2011 Nov;401(9):2811-9
references: 21922305
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 15;878(30):3193-7
references: 20974553
references: J Pharm Biomed Anal. 2011 Jan 25;54(2):426-32
references: 20880646
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 1;878(19):1590-8
references: 20435530
references: Med Res Rev. 2003 May;23(3):275-301
references: 12647311
references: Biochim Biophys Acta. 2003 Oct 13;1623(2-3):88-97
references: 14572906
references: Biopharm Drug Dispos. 1997 Dec;18(9):791-801
references: 9429743
references: Anal Biochem. 1979 Nov 1;99(2):352-64
references: 574723
references: Anal Bioanal Chem. 2010 Jul;397(6):2349-56
references: 20496030
references: Anal Chem. 1994 Nov 1;66(21):3814-22
references: 7802261
references: Clin Chim Acta. 2011 Jan 30;412(3-4):277-85
references: 21034726
references: Arch Biochem Biophys. 2005 Dec 15;444(2):92-9
references: 16309624
references: Comp Biochem Physiol C Comp Pharmacol. 1981;69(2):375-8
references: 6116580
references: J Biol Chem. 1986 Oct 15;261(29):13542-5
references: 3759977
references: J Chromatogr. 1992 Sep 2;579(2):225-35
references: 1429970